IMPACT Medicom
Avsnitt

Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL

IMPACT Medicom
Dela

In this podcast episode, Dr. Michael Chu discusses the management of peripheral neuropathy associated with the use of brentuximab vedotin for the first-line treatment of classical Hodgkin Lymphoma.

Our Guest
Dr. Michael Chu is a clinician scientist at the Cross Cancer Institute and an Associate Professor at the University of Alberta in Edmonton, Alberta.

This podcast episode was sponsored by Pfizer Canada Inc.

If you enjoyed our podcast episode, please review and subscribe. For other medical education content, visit our website at: https://www.impactmedicom.com (https://www.impactmedicom.com/).

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör IMPACT Medicom. Innehållet i podden är skapat av IMPACT Medicom och inte av, eller tillsammans med, Poddtoppen.